Abstract
Alzheimers disease is a chronic and progressive neurodegenerative disorder. The presence of functional cannabinoid CB2 receptors in central nervous system (CNS) has provoked that this receptor and its agonist ligands are now considered as promising pharmacological targets for neurological diseases. Herein, we review the evidences supporting the potential role of the ECS as a therapeutic target, focused on CB2 receptor and its ligands, for the treatment of Alzheimer s disease.
Keywords: Cannabinoid, endocannabinoid, cannabinoid receptors, alzheimer's disease, dementia, CB2 agonist
Mini-Reviews in Medicinal Chemistry
Title: Cannabinoid System in Neurodegeneration: New Perspectives in Alzheimers Disease
Volume: 9 Issue: 5
Author(s): N. E. Campillo and J. A. Paez
Affiliation:
Keywords: Cannabinoid, endocannabinoid, cannabinoid receptors, alzheimer's disease, dementia, CB2 agonist
Abstract: Alzheimers disease is a chronic and progressive neurodegenerative disorder. The presence of functional cannabinoid CB2 receptors in central nervous system (CNS) has provoked that this receptor and its agonist ligands are now considered as promising pharmacological targets for neurological diseases. Herein, we review the evidences supporting the potential role of the ECS as a therapeutic target, focused on CB2 receptor and its ligands, for the treatment of Alzheimer s disease.
Export Options
About this article
Cite this article as:
Campillo E. N. and Paez A. J., Cannabinoid System in Neurodegeneration: New Perspectives in Alzheimers Disease, Mini-Reviews in Medicinal Chemistry 2009; 9 (5) . https://dx.doi.org/10.2174/138955709788167628
DOI https://dx.doi.org/10.2174/138955709788167628 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Does a Pro-Inflammatory Process Precede Alzheimers Disease and Mild Cognitive Impairment?
Current Alzheimer Research Oncogenic Role of SET/I2PP2A for Gynecologic Cancers
Current Drug Targets Emerging and Alternative Therapies For Parkinson Disease: An Updated Review
Current Pharmaceutical Design Editorial [Continue the Great Journey of Success!]
Current Molecular Medicine Chaperonin GroEL: Structure and Reaction Cycle
Current Protein & Peptide Science FDG PET/MR Imaging in Major Neurocognitive Disorders
Current Alzheimer Research Molecular Links Between Endothelial Dysfunction and Neurodegeneration in Alzheimer's Disease
Current Alzheimer Research The Neurovascular Unit: Focus on the Regulation of Arterial Smooth Muscle Cells
Current Neurovascular Research Beneficial Effects of Dietary Supplements Against Mitochondrial Dysfunction and Apoptosis in Neurodegenerative Diseases
Current Pharmacogenomics and Personalized Medicine Microglia and its Genetics in Alzheimer's Disease
Current Alzheimer Research Frontotemporal Dementia Caused by CHMP2B Mutations
Current Alzheimer Research Meet Our Editorial Board Member
Current Alzheimer Research Functionalized magnetic nanoparticles for biomedical applications
Current Pharmaceutical Design Aging and Neuroinflammatory Disorders: New Biomarkers and Therapeutic Targets
Current Pharmaceutical Design The Biology of Neurotrophins, Signalling Pathways, and Functional Peptide Mimetics of Neurotrophins and their Receptors
CNS & Neurological Disorders - Drug Targets Curcumin, Resveratrol and Cannabidiol as Natural Key Prototypes in Drug Design for Neuroprotective Agents
Current Neuropharmacology Does Ceruloplasmin Defend Against Neurodegenerative Diseases?
Current Neuropharmacology Role of Adenosine Receptors in Rare Neurodegenerative Diseases with Motor Symptoms
Current Protein & Peptide Science New Developments in Peroxidation of Polyunsaturated Fatty Acids
Letters in Organic Chemistry The Future of Neuroregenerative Therapy for Parkinson’s Disease
Current Tissue Engineering (Discontinued)